Robert Koch InstituteRobert Koch Institute, Berlin
Nordufer 20
D-13353 Berlin-Wedding


The Robert Koch Institute is one of the central institutions for health protection in Germany. It serves the Federal Ministry of Health as a central scientific institution in the field of biomedicine. The Institute combines risk research with political advice. Its most important tasks include protection against infectious diseases and the analysis of the health situation in Germany. Scientists here have a “rapid task force” to investigate regional outbreaks of epidemics through the use of surveys and analysis of the quality of life and health risks for people in Germany. These analyses are channeled into regular health reporting, which – besides research into infectious diseases – has become one of the trademarks of the Institute. In addition, in April 2014, a team of interdisciplinary scientists arrived in Guinea to investigate a possible epidemic of Ebola hemorrhagic fever (EHF) amongst wildlife in the region where human cases occurred, in efforts of predicting the risk of virus transmission to humans.

Center Director: Dr. Lothar H. Wieler, Heinz Ellerbrok
Affiliated Researchers:T. Wolff, B. Schweiger, A. Nitsche, N. Bannert,

Technical University of MunichInstitute of Virology, Technical University of Munich
Trogerstr. 30
81675 München


Institute of Virology, Technische Universität München / Helmholtz Zentrum München:  Research at the Institute of Virology is geared toward pathogenic human viruses such as hepatitis viruses, HIV, poxviruses or SARS virus.  Their study focuses on molecular details of the viral replication cycle, host-pathogen interactions and the role of immunity in viral diseases. The institute is equipped with state-of-the-art instrumentation, BSL2 and BSL3 laboratories and an immune monitoring unit.  In spring 2013, the Global Virus Network met in Munich to discuss the topics of control of chronic and emerging viral infections. The workshop highlighted the Durability of Vaccine-induced Immune Response, and was led by GVN Co-Founder and Scientific Director, Dr. Robert Gallo and Ulrike Protzer, among other speakers at the event.

Ulrike ProtzerCenter Director: Prof. Ulrike Protzer, M.D.
Affiliated Researchers:Volker Bruss, Mathias Heikenwälder

Philipps-Universitat MarburgInstitute for Virology, Philipps-Universität Marburg
Institut für Virologie
Hans-Meerwein-Straße 2
D-35043 Marburg


The Institute for Virology, University of Marburg, deals with the study of viral infections, which are significantly influenced by the pathogen exchange between animals and humans.  These include a wide array of emerging and zoonotic viruses. Among the research responsibilities, the Institute focuses on molecular biology and pathogenesis of filoviruses, Lassa virus, Nipah virus, as well as human and avian influenza viruses. Another focus is translational research mainly in developing vaccines against novel and re-emerging highly pathogenic viruses. The Institute hosts a modern BSL-4 laboratory to investigate efficacy of vaccines and antivirals and fulfill its duties in providing diagnostics for patients with life-threatening viral diseases. 

Becker-100Center Director: Prof. Stephan Becker
Affiliated Researchers: Drs. Markus Eickmann, Eva Friebertshäuser, Hans-Dieter Klenk, Andrea Maisner, Mikhail Matrosovich, Thomas Strecker


The Research Center for Emerging Infections and Zoones (RIZ)

University of Veterinary Medicine in Hanover
Bünteweg 17
30559 Hanover

The Research Center for Emerging Infections and Zoones (RIZ) is a state of the art ‘one health’ research center embedded in the University of Veterinary Medicine in Hannover
The RIZ offers two state of the art research facilities, the Research Laboratory for Infectious Diseases and the Center for Zoonosis Research. The Center for Zoonosis Research has more than 2000 square meters of biosafety level 2 laboratories. It consists out of 3 floors with a total working area of more than 40 laboratories which are all equipped with the most modern equipment. The Research Laboratory for Infectious Diseases consists out of large animal facilities under biosafety level 2 and 3. The Research Center with Large Animal Facilities is planned to be operational in 2016.

Dr. Ab Osterhaus

Center Director: Ab Osterhaus
Affiliated Researchers:
Stefanie Becker, Bernd Lepenies, Martin Ludlow, Erhard van der Vries, Josanne Verhagen, Georges Verjans